Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/09/2003US20030190733 Desaturase genes and uses thereof
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190607 Polymorphisms in human pyruvate dehydrogenase E1 beta (PDH E1 beta) gene; for analysing allelic variation; bioinformatic applications
10/09/2003US20030190597 For drug screening and development, exposing to a compound that paralyzes or kills nematoda
10/09/2003US20030190375 Therapeutical use of sophora flavescens or sophora subprostrata extracts
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190360 Chronotherapeutic pharmaceutical formulation comprising core containing active agent and delayed release compression coating comprising a natural or synthetic gum applied onto surface of core
10/09/2003US20030190357 Compositions for delivery of a cortisol antagonist
10/09/2003US20030190342 Administering to the vascular tissue a therapeutically effective amount of Saratin polypeptide to prevent platelet adhesion, so inhibiting thrombosis and restenosis
10/09/2003US20030190315 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines
10/09/2003CA2481258A1 Antidiabetic agents
10/09/2003CA2481253A1 Vegf peptides and their use
10/09/2003CA2481236A1 Volume efficient controlled release dosage form
10/09/2003CA2481221A1 Use of angiotensin 1-7 for enhancing cardiac function
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2480695A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480372A1 Combination therapy using trefoil peptides
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2479110A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2474512A1 Method for producing pseudo islets
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350516A1 Compositions for preventing or ameliorating multiple risk factor syndromes
10/08/2003EP1350515A1 Low-dose potassium supplementation for the prevention and treatment of hypertension
10/08/2003EP1350514A2 Therapeutic use of cis-element decoys in vivo
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349919A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349864A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349850A1 Sodium channel modulators derived from 2-piperidylimidazoles
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349846A1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349578A2 Medicinal association of a biguanine (metformin) and arginine
10/08/2003EP1349576A2 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological di
10/08/2003EP1349563A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349547A2 Use of 5-aminolevulinic acid for the prophylaxis of restenosis
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1144421B1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
10/08/2003EP1105377B1 Pyrimidinone derivatives for the treatment of atherosclerosis
10/08/2003EP1045918A4 G protein-related kinase mutants in essential hypertension
10/08/2003EP1001935B1 Indole derivatives as mcp-1 receptor antagonists
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003CN1447857A Agonist anti-TRK-C monoclonal antibodies
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447807A Chromenone derivatives and their use for treating diseases in conjunction with 5-HT1A receptors and/or dopamine D2 receptors
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1447693A Use of angiotensin Ôàí antagonists
10/08/2003CN1447691A Pharmaceutical combination of angiotensin Ôàí antagonists and ace inhibitors
10/08/2003CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel
10/08/2003CN1447688A Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
10/08/2003CN1446912A Reformed lyophylization preparation of recombinant staphylokinase (r-Sak), its preparing method and application
10/08/2003CN1446824A Vasoconstriction factor and preparation method as well as its application in pharmacy
10/08/2003CN1446816A Compound of geniposide acid, gentio-bioside medication and its preparation method
10/08/2003CN1446585A Combination object of half solid framework preparation of gingko leaf extract product
10/08/2003CN1446584A Addition agent of pyrithioxine hydrochloride utilized for injection
10/08/2003CN1446555A Medicine for treating insufficiency of the kidney-yang syndrome and its preparing method
10/08/2003CN1446552A Steaming and washing liquid for treating hemorrhoids
10/08/2003CN1446551A Medicine for treating arteriosclerosis and coronary heart disease and its preparation method
10/08/2003CN1446536A Combination of semisolid framework preparation of nimodipine
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/08/2003CN1123571C 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists
10/08/2003CN1123359C Treatment of cerebral ischomia and cerebral damage with neuroprotective agent
1 ... 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 ... 1595